Delivery Order SPE2DB24D2100-SPE2DB25FBENL
- Not listed
- The Defense Logistics Agency awarded a $5,168.16 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX under a firm fixed price contract, with an ultimate completion date of August 13, 2025. This is a non-set-aside, competitively awarded delivery order issued on July 23, 2025, with performance to be completed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a critical pharmaceutical distributor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX, valued at $3,419.20, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $3,419.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Botox, with a completion date of June 24, 2025. This is a non-set-aside competitive award executed as a child contract under AmerisourceBergen's broader pharmaceutical supply arrangements with DLA. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $7,227.00 to AmerisourceBergen Drug Corp for the supply of Botox 200 unit vials, with an ultimate completion date of August 25, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Botox 100-unit vials, with a ceiling value of $2,153.40 and an ultimate completion date of June 24, 2025. This non-competitive delivery order carries firm fixed pricing and represents a competitive award under an existing contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters location. This delivery order is...
- The Defense Logistics Agency awarded a $42,739.50 delivery order to AmerisourceBergen Drug Corp for the supply of Botox 200 unit vials, with an ultimate completion date of June 23, 2025. This non-set-aside contract employs firm fixed price terms and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,419.20 for 200-unit vials of BOTOX on July 21, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999...
- The Defense Logistics Agency awarded a $12,821.85 delivery order to AmerisourceBergen Drug Corp for the supply of Botox 200 unit vials. This firm fixed price contract, with an ultimate completion date of August 14, 2025, represents a direct procurement of the pharmaceutical product without set-aside designation. The award was issued on July 24, 2025, with performance occurring at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order operates as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,273.95 to AmerisourceBergen Drug Corp for the supply of Botox 200 unit vials, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order was issued under no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $3,613.50 to AmerisourceBergen Drug Corp for the supply of BOTOX 200 Unit Vials on August 8, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBENLDelivery Order
The Defense Logistics Agency awarded a $89,752.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Botox, with performance in Conshohocken, Pennsylvania and a completion date of June 27, 2025. This is an unset-aside, competitively awarded delivery order that represents a child contract under AmerisourceBergen's larger prime contract vehicle with DLA. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor headquartered in Pennsylvania, serving military and veteran healthcare systems with an extensive portfolio of pharmaceutical products and medical supplies. This delivery order falls under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract vehicle encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, serving customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $89.8k | 6/5/25 |